Arms race in robotic surgery to compete with da Vinci

Becka DeSmidt, Technology Insights

Between concerns about Intuitive’s irresponsible sales practices and lax training standards, questionable clinical benefits, and difficult-to-justify cost, an alternative to its da Vinci surgical robot would be a welcome arrival on the market.

Unfortunately for wishful thinkers, Intuitive’s competitors are still years away from finalizing their products, gaining FDA approval, and becoming available for installment in hospitals and health systems.

Members, unlock more content

Members of Technology Insights can log in to advisory.com to read more.

Not a member? Visit our website or contact us to learn more.

Log in to access this.

Full access to this content is reserved for Service Line Strategy Advisor members.
Log in or learn how membership works.